Login
$EGY
$6.39 -$0.11 (1.69%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash
Receivables:
Trade
Accounts with joint venture owners, net of allowance for credit losses of $3.1 million and $2.7 million, respectively
Foreign income taxes receivable
Other, net of allowance for credit losses of $0.4 million and $— million, respectively
Crude oil inventory
Prepayments and other
Current assets held for sale
Total current assets
Crude oil, natural gas and NGLs properties and equipment, net
Other noncurrent assets:
Restricted cash
Value added tax and other receivables
Right of use operating lease assets
Right of use finance lease assets
Deferred tax assets
Abandonment funding
Other long-term assets
Noncurrent assets held for sale
Total assets
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable
Nonrelated Party
Related Party
Accrued liabilities and other
Operating lease liabilities - current portion
Finance lease liabilities - current portion
Foreign income taxes payable
Current liabilities held for sale
Total current liabilities
Asset retirement obligations
Operating lease liabilities - net of current portion
Finance lease liabilities - net of current portion
Deferred tax liabilities
Long-term debt
Other long-term liabilities
Noncurrent liabilities held for sale
Total liabilities
Shareholders’ equity:
Preferred stock, $25 par value; 500,000 shares authorized, none issued
Common stock, $0.10 par value; 160,000,000 shares authorized, 124,320,737 and 123,017,656 shares issued, and 105,191,778 and 104,258,253 shares outstanding, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Less treasury stock, 19,128,959 and 18,759,403 shares, respectively, at cost
Retained earnings
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support